Towards Multi-Organoid Systems for Drug Screening Applications

particulate drug delivery systems in dermal applications

O-5: Preparation of Multi-Component Drug Delivery Systems

Background: Despite global interest, the development of single step processes for the preparation of effective drug delivery systems still faces numerous challenges. There is great demand for processing methods that are efficient, flexible, scalable and economical for the generation of wide range of encapsulated structures. Over the past few decades, electrohydrodynamic (EHD) processing has rec...

Organoid Models and Applications in Biomedical Research.

Recent technical advances in the stem cell field have enabled the in vitro generation of complex structures resembling whole organs termed organoids. Most of these approaches employ three-dimensional (3D) culture systems that allow stem cell-derived or tissue progenitor cells to self-organize into 3D structures. These systems evolved, methodologically and conceptually, from classical reaggregat...

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

Cancer drug screening in patient-derived cells holds great promise for personalized oncology and drug discovery but lacks standardization. Whether cells are cultured as conventional monolayer or advanced, matrix-dependent organoid cultures influences drug effects and thereby drug selection and clinical success. To precisely compare drug profiles in differently cultured primary cells, we develop...

Microfluidic Devices for Drug Delivery Systems and Drug Screening

Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow rates of multiphase fluids, microfluidic technology enables the generation of highly stable, uniform, mo...